131I-rituximab
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for 131I-rituximab, covering 2012-09-05 to 2012-11-14. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Study of 131I-rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL) [Phase 2]